Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non-Small-Cell Lung Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Justin F,Gainor ^[1] ; Diane,Tseng ^[1] ; Satoshi,Yoda ^[1] ; Ibiayi,Dagogo-Jack ^[1] ; Luc,Friboulet ^[2] ; Jessica J,Lin ^[1] ; Harper G,Hubbeling ^[1] ; Leila,Dardaei ^[1] ; Anna F,Farago ^[1] ; Katherine R,Schultz ^[1] ; Lorin A,Ferris ^[1] ; Zofia,Piotrowska ^[1] ; James,Hardwick ^[3] ; Donghui,Huang ^[3] ; Mari,Mino-Kenudson ^[4] ; A John,Iafrate ^[4] ; Aaron N,Hata ^[1] ; Beow Y,Yeap ^[1] ; Alice T,Shaw ^[1]

作者单位： Department of Medicine, Massachusetts General Hospital, Boston, MA. ^[1] Gustave Roussy Cancer Campus, Université Paris Saclay, INSERM U981. ^[2] Pfizer Worldwide Research and Development, La Jolla, CA. ^[3] Department of Pathology, Massachusetts General Hospital, Boston, MA. ^[4]

关键词 ALK RET ROS1 acquired resistance crizotinib

DOI 10.1200/PO.17.00063

PMID 29333528

发布时间 2024-03-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览7

JCO precision oncology

2017年2017卷

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non-Small-Cell Lung Cancer.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non-Small-Cell Lung Cancer.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

检索历史清除